We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Oncology Drug Reference Sheet: Amivantamab-Vmjw.
- Authors
Anglin, Aileen
- Abstract
The article offers information on the U.S. Food and Drug Administration (FDA) approved amivantamab-vmjw for adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion variants, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy. It also hihglighst that the package insert carries the following warnings and precautions: infusion-related reactions.
- Subjects
LUNG cancer; MONOCLONAL antibodies; PHARMACY information services; PATIENT education; ONCOLOGY
- Publication
ONS Voice, 2021, Vol 36, Issue 12, p37
- ISSN
2475-6938
- Publication type
Article